REPORT HIGHLIGHT
Subdural Electrodes Market size was valued at USD 48.9 Million in 2022, expanding at a CAGR of 8.7% from 2023 to 2030.
Subdural electrodes are medical devices placed beneath the dura mater, a protective membrane surrounding the brain, to monitor brain activity or locate seizure origins in cases of epilepsy. In cases where conventional drug therapies fail to control epilepsy, subdural electrodes are implanted to conduct intracranial EEG (iEEG) monitoring. This procedure helps pinpoint specific regions of the brain responsible for triggering seizures, which can then be considered for surgical removal to alleviate the condition.
Subdural Electrodes Market - Market Dynamics:
- The rising incidence of neurological disorders drives market growth
- An influential factor driving the subdural electrodes market is the increasing prevalence of neurological disorders, including epilepsy, brain tumors, and neurodegenerative diseases. These conditions are on the rise, leading to a growing demand for precise diagnostic and therapeutic solutions that incorporate subdural electrodes for accurate monitoring and intervention. For example, recent data from NCBI highlights the significant impact of epilepsy, ranking as the third most common neurological disorder globally, affecting over 70 million individuals.
- The condition exhibits a point prevalence of 6.38 per 1,000 people and a lifetime prevalence of 7.6 per 1,000 people, as reported in a comprehensive meta-analysis of 222 studies. The incidence is estimated at 61.44 per 100,000 person-years. Furthermore, epilepsy's prevalence varies, with rates ranging from 10.2 to 23.3 per 1,000 people in less developed countries and 2.7 to 6.2 per 1,000 people in more developed regions. Notably, epilepsy is disproportionately prevalent in underdeveloped nations, accounting for over 90% of the global burden. Consequently, these statistics are anticipated to drive market growth in the foreseeable future.
Subdural Electrodes Market - Key Insights:
- According to insights provided by our research analyst, the global Subdural Electrodes market is poised for robust growth, with an estimated annual CAGR of approximately 8.7% throughout the forecast period spanning from 2023 to 2030. The Subdural Electrodes sector is set to experience substantial expansion, primarily driven by the increasing prevalence of neurological disorders.
- Furthermore, when examining the choice of materials, the platinum category is anticipated to command a significant portion of the market share in the foreseeable future.
- These factors underscore the promising growth prospects and opportunities within the Subdural Electrodes market.
Subdural Electrodes Market- Segmentation Analysis:
The worldwide Subdural Electrodes Market is categorized based on material, type, end user, and region. Concerning material, the global Subdural Electrodes market presents two distinct options: platinum and stainless steel. Platinum is foreseen to maintain a substantial market presence in the foreseeable future due to its numerous benefits. These advantages encompass improved electrical conductivity, reduced patient infection risks, and superior compatibility with the biological environment.
Subdural Electrodes Market- Competitive Landscape:
Prominent companies in this industry comprise Alliance Biomedica Private Limited, CorTec GmbH, Integra Lifesciences Corporation, Inomed Medizintechnik Gmbh, DIXI MEDICAL (Dixi), UNIQUE MEDICAL Co., LTD, PMT Corporation, Ad-Tech Medical Instrument Corporation (Archimed), Natus Medical Incorporated, and Rhythmlink International Inc. These industry leaders have consistently demonstrated their commitment to advancing the field of medical devices and technology, contributing significantly to market growth through their innovative solutions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SUBDURAL ELECTRODES MARKET KEY PLAYERS
- DIXI MEDICAL (Dixi)
- CorTec GmbH
- PMT Corporation
- Ad-Tech Medical Instrument Corporation (Archimed)
- UNIQUE MEDICAL Co., LTD
- Alliance Biomedica Private Limited
- Integra Lifesciences Corporation
- Inomed Medizintechnik Gmbh
- Natus Medical Incorporated
- Rhythmlink International Inc.
GLOBAL SUBDURAL ELECTRODES MARKET, BY MATERIAL
GLOBAL SUBDURAL ELECTRODES MARKET, BY TYPE
GLOBAL SUBDURAL ELECTRODES MARKET, BY END USER
- Hospitals & ASCs
- Specialty Clinics
- Others
GLOBAL SUBDURAL ELECTRODES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA